Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI
出版年份 2020 全文链接
标题
Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI
作者
关键词
-
出版物
Hepatology International
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-21
DOI
10.1007/s12072-020-10040-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
- (2019) KLCA Korean Liver Cancer Association et al. Gut and Liver
- Meta-analysis of the accuracy of Liver Imaging Reporting and Data System category 4 or 5 for diagnosing hepatocellular carcinoma
- (2019) Dong Hwan Kim et al. GUT
- Is It Time to Expand the Definition of Washout Appearance in LI-RADS?
- (2019) Kathryn J. Fowler et al. RADIOLOGY
- Gadoxetic Acid–enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases
- (2019) Dong Hwan Kim et al. RADIOLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm
- (2018) Maxime Ronot et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014
- (2018) Tyler J. Fraum et al. RADIOLOGY
- Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
- (2018) Ijin Joo et al. EUROPEAN RADIOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ
- (2017) An Tang et al. Abdominal Radiology
- Comparison of hepatocellular carcinoma in Eastern versus Western populations
- (2016) Su Pin Choo et al. CANCER
- Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images
- (2014) Heon-Ju Kwon et al. ABDOMINAL IMAGING
- LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions
- (2014) Donald G. Mitchell et al. HEPATOLOGY
- Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI
- (2013) An Tang et al. Expert Review of Gastroenterology & Hepatology
- 1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY
- (2012) J.M. Llovet et al. JOURNAL OF HEPATOLOGY
- Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: Predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced mr imaging
- (2012) Emilio Quaia et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases
- (2010) Gilles Piana et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started